Immunome (IMNM) shares jumped in the most recent session on above-average trading volume. Trend in upward earnings estimate revisions from analysts points to the potential for further share-price strength, suggesting a constructive near-term outlook for the stock.
Immunome (IMNM) shares jumped in the most recent session on above-average trading volume. Trend in upward earnings estimate revisions from analysts points to the potential for further share-price strength, suggesting a constructive near-term outlook for the stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
